Oruka Therapeutics, Inc.(ORKA US)
$105.35+0.360.34%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -9.9 | -83.7 | -105.4 | -116.3 | |||||||||||||||||||
| Depreciation & Amortization | 0.1 | 0.0 | 0.1 | 0.1 | |||||||||||||||||||
| Stock Based Compensation | - | - | - | 15.2 | |||||||||||||||||||
| Change in Working Capital | -1.7 | 11.6 | -2.6 | 2.0 | |||||||||||||||||||
| Other Non-Cash Items | 0.6 | 14.3 | 19.7 | 8.0 | |||||||||||||||||||
| Net Cash from Operating Activities | -10.9 | -57.8 | -88.2 | -90.9 | |||||||||||||||||||
| -Investments in Property, Plant & Equipment | -0.0 | -0.2 | -0.2 | -0.3 | |||||||||||||||||||
| -Acquisitions Net | - | - | - | - | |||||||||||||||||||
| -Purchases of Investments | - | -329.9 | -521.0 | -299.8 | |||||||||||||||||||
| Sales/Maturities of Investments | - | - | 424.4 | 268.4 | |||||||||||||||||||
| Other Investing Activities | - | - | - | -122.4 | |||||||||||||||||||
| Net Cash from Investing Activities | -0.0 | -330.1 | -96.7 | -154.0 | |||||||||||||||||||
| Net Debt Issuance | - | - | - | - | |||||||||||||||||||
| Net Stock Issuance | - | 449.5 | 170.3 | 41.0 | |||||||||||||||||||
| -Net Dividends Paid | - | - | - | - | |||||||||||||||||||
| Other Financing Activities | - | - | - | 169.9 | |||||||||||||||||||
| Net Cash from Financing Activities | - | 449.5 | 170.3 | 210.9 | |||||||||||||||||||
| Effect of Forex Changes | - | -37.4 | - | - | |||||||||||||||||||
| Net Change in Cash | -10.9 | 24.1 | -14.6 | -34.1 | |||||||||||||||||||
| Cash at End of Period | 42.4 | 61.6 | 46.9 | 253.1 | |||||||||||||||||||
| Operating Cash Flow | -10.9 | -57.8 | -88.2 | -90.9 | |||||||||||||||||||
| -Capital Expenditure | -0.0 | -0.2 | -0.2 | -0.3 | |||||||||||||||||||
| Free Cash Flow | -10.9 | -58.0 | -88.4 | -91.2 | |||||||||||||||||||
| Millions USD (ex. Per Share) | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -9.9 | -83.7 | -105.4 | -116.3 | |||||||||||||||||||
| Depreciation & Amortization | 0.1 | 0.0 | 0.1 | 0.1 | |||||||||||||||||||
| Stock Based Compensation | - | - | - | 15.2 | |||||||||||||||||||
| Change in Working Capital | -1.7 | 11.6 | -2.6 | 2.0 | |||||||||||||||||||
| Other Non-Cash Items | 0.6 | 14.3 | 19.7 | 8.0 | |||||||||||||||||||
| Net Cash from Operating Activities | -10.9 | -57.8 | -88.2 | -90.9 | |||||||||||||||||||
| -Investments in Property, Plant & Equipment | -0.0 | -0.2 | -0.2 | -0.3 | |||||||||||||||||||
| -Acquisitions Net | - | - | - | - | |||||||||||||||||||
| -Purchases of Investments | - | -329.9 | -521.0 | -299.8 | |||||||||||||||||||
| Sales/Maturities of Investments | - | - | 424.4 | 268.4 | |||||||||||||||||||
| Other Investing Activities | - | - | - | -122.4 | |||||||||||||||||||
| Net Cash from Investing Activities | -0.0 | -330.1 | -96.7 | -154.0 | |||||||||||||||||||
| Net Debt Issuance | - | - | - | - | |||||||||||||||||||
| Net Stock Issuance | - | 449.5 | 170.3 | 41.0 | |||||||||||||||||||
| -Net Dividends Paid | - | - | - | - | |||||||||||||||||||
| Other Financing Activities | - | - | - | 169.9 | |||||||||||||||||||
| Net Cash from Financing Activities | - | 449.5 | 170.3 | 210.9 | |||||||||||||||||||
| Effect of Forex Changes | - | -37.4 | - | - | |||||||||||||||||||
| Net Change in Cash | -10.9 | 24.1 | -14.6 | -34.1 | |||||||||||||||||||
| Cash at End of Period | 42.4 | 61.6 | 46.9 | 253.1 | |||||||||||||||||||
| Operating Cash Flow | -10.9 | -57.8 | -88.2 | -90.9 | |||||||||||||||||||
| -Capital Expenditure | -0.0 | -0.2 | -0.2 | -0.3 | |||||||||||||||||||
| Free Cash Flow | -10.9 | -58.0 | -88.4 | -91.2 | |||||||||||||||||||